You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

 

1820 Results
The resources in this toolkit will help radiologists and other imaging professionals provide consistent and high-quality imaging according to best...
Guidelines and Advice
Status: Current
Jun 2017
Guidelines and Advice
Status: Current
Version: 1
Sep 2017
Guidelines and Advice
Status: Current
ID: GL-C50-22
Oct 2015
Regimen
Cancer Type:
Gastrointestinal, 
Colorectal, 
Small bowel and appendix
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
    capecitabine
New Drug Funding Program
    Bevacizumab (Biosimilar) - Metastatic Colorectal, Small Bowel, or Appendiceal Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
bevacizumab,
oxaliplatin,
capecitabine
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2023
Cancer facts
Feb 2019
Guidelines and Advice
Status: Current
ID: PET 11
Aug 2011
Guidelines and Advice
Status: Current
ID: GL-C50-32
Jan 2021
Guidelines and Advice
Status: In-Review
ID: FA 1
Jul 2014

Pages